Support our Foundation of Myology project
1722 news items
Recommendations for cardiac monitoring of adults with canalopathy on mexiletine
On 20/12/2024
Cardiac monitoring is recommended in adults with muscular canalopathy treated for myotonia with mexiletine (Namuscla®), due to a possible pro-arrhythmic effect of the product. To…
Viltolarsen slows the decline in respiratory function in walking and non-walking patients
On 19/12/2024
A drug targeting exon 53 skipping of the DMD gene authorised in the United States and Japan, viltolarsen was evaluated for 48 weeks (80mg/kg/week) in…
Real-life data for gene therapy in SMA: the German-speaking area experience
On 17/12/2024
A transnational registry containing real-life data from patients with SMN1-related proximal spinal muscular atrophy (SMA) has been set up in Germany, Austria and German-speaking Switzerland:…
Dimitrios Kourtzas awarded Master Prize at JSFM 2024 – Interview
On 16/12/2024
Dimitrios Kourtzas has been awarded the Master’s Prize for his research project on collagen VI (COLVI)-related disorders at the JSFM 2024. He just started…
CAR-T cells to treat severe forms of Lambert-Eaton syndrome
On 16/12/2024
German researchers report the case of a patient with Lambert-Eaton syndrome (or LEMS, a presynaptic disorder of the neuromuscular junction very often of paraneoplastic origin)…
Report on the ‘1,000 researchers in schools’ operation
On 13/12/2024
The 12th edition of the ‘1,000 researchers in schools’ operation has just come to an end. This year it ran from 4 November to 6…
New data on life expectancy in DM2
On 13/12/2024
Of the 125 Dutch patients with myotonic dystrophy type 2 (DM2) recorded in the Dutch neuromuscular database, 26 died between 2000 and 2023 : the…
ERN EURO-NMD webinar, 19 Dec. : Prof. Edoardo Malfatti (France)
On 13/12/2024
Novel approaches and future developments in Neuromuscular Pathology Thursday 19 December 2024 – 16:00 – 17:00 Paris time Prof. Edoardo Malfatti (Paris-Est AP-HP, France) >…
An algorithm to assist diagnostic for seronegative autoimmune myasthenia gravis
On 12/12/2024
At the 275th workshop of the European Neuromuscular Centre (ENMC), held in February 2024 in the Netherlands, experts and patient representatives met to review the…
From diagnosis to treatment, antisynthetase syndrome is attracting international attention
On 11/12/2024
In France, the National Data Bank for Rare Diseases lists 1,156 patients followed up in Centres of Reference or Competence for an anti-synthetase syndrome (SAS),…
Post-hoc news on efgartigimod in anti-RACh myasthenia gravis
On 10/12/2024
The phase III placebo-controlled Adapt trial and its open-label extension Adapt+ evaluated the efficacy of efgartigimod, an anti-FcRN, in generalised autoimmune myasthenia gravis. They ended…
Tribute to Michel Fardeau, pioneer of myology
On 09/12/2024
Michel Fardeau passed away on 6 December at the age of 95. A medical researcher, he began his career as a Clinic Director at Paris…
Methylation studies to help with the molecular diagnosis of FSHD
On 09/12/2024
The Italian consortium dedicated to facioscapulohumeral muscular dystrophy (FSHD) reports on its experience in integrating methylation studies into the routine diagnosis of this myopathy with…
The case of premature twins with SMA who received early treatment
On 06/12/2024
American clinicians report their experience of gene therapy treatment of two twins with proximal spinal muscular atrophy (SMA) who were born prematurely. The twins were…
DMD: French recommandations on corticoids
On 06/12/2024
On the basis of a review of the literature, the Filnemus neuromuscular rare diseases health network and the French Paediatric Neurology Society (SFNP), including clinicians…
ERN EURO-NMD webinar, 12 Dec.: Prof. Dr. Norma Romero (France)
On 06/12/2024
The role of muscle biopsy in Congenital Myopathies Thursday 12 December 2024 – 16:00 – 17:00 Paris time Prof. Dr. Norma Romero (Institute of Myology,…
Stamina analyses the treatment of myasthenia in ‘real life’ in France
On 05/12/2024
Based on data from the French National Health Data System (SNDS), the Stamina study reviewed the management of two groups of adults with autoimmune myasthenia…
Three-dimensional movement analysis measures the effectiveness of gene therapy in SMA
On 04/12/2024
French clinicians report the development and results of a follow-up protocol for infants with SMA treated with gene therapy (onasemnogene abeparvovec or Zolgensma®): 23 children…
ERN EURO-NMD webinar 5 Dec.: Prof. Werner Stenzel (Germany)
On 03/12/2024
The role of muscle biopsy in inflammatory myopathies Thursday 5 December 2024 – 16:00 – 17:00 Paris time Prof. Werner Stenzel (Charité – Universitätsmedizin, Berlin, Germany)…
A new natural history study in SMA
On 03/12/2024
An international consortium of clinicians with expertise in SMA reports new natural history data in this disease: the study population consisted of 226 patients with…
